Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma

Published:2020-02-05 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Li Li¹,Rao Xiaosong²,Wen Zhaohong³,Ding Xiaosheng¹,Wang Xiangyi¹,Xu Weiran¹,Meng Chao¹,Yi Yuting³,Guan Yanfang³,Chen Yongshen³,Wang Jiayin⁴,Jun Liang¹

Affiliation:

1. Department of Oncology, Peking University International Hospital, Beijing 102206, P.R. China

2. Department of Pathology, Peking University International Hospital, Beijing 102206, P.R. China

3. Geneplus‑Beijing Institute, Beijing 102206, P.R. China

4. Department of Computer Science and Technology, School of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice;BMC Cancer;2024-06-03

2. The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy;Frontiers in Immunology;2024-04-11

3. Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma;Biomarker Research;2024-02-14

4. ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma;BMC Gastroenterology;2024-01-02

5. The stage-dependent prognostic role of ARID1A in hepatocellular carcinoma;Translational Cancer Research;2023-11